News Detail
Amsterdam, 11 Feb 2025: The European Medicines Agency (EMA) and the European Commission have developed a standard procedure for certain high-risk medical device manufacturers to ask for scientific advice from a panel of experts regarding their clinical development strategies and ......
View Details
Source : Regulatory Focus
European Medicines Agency
EMA
European Commission
standard procedure
high-risk medical device manufacturers
clinical development strategies
clinical investigationsscientific advice from a panel of experts
Related News
- NPPA fixes retail price of 42 formulations, revise prices based on review orders (11-02-2025)
- DCGI calls for focused interventions to enhance drug quality (11-02-2025)
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)
- China's health regulator defends quality of local generic drugs (10-02-2025)